Assistant Professor at the Children's Hospital of Philadelphia and the University of Pennsylvania.
While Hospital-Acquired C difficile Cases Have Decreased, Community-Acquired Cases Have Risen
Joseph Zackular, PhD highlights targeting high-risk groups for vaccination and shares insights into the future of mRNA vaccine development for C diff.
Read More
Targeting the C Diff Pathogen and Its Immune-Suppressing Toxins
Joseph Zackular, PhD suggests that mRNA vaccines and monoclonal antibodies could offer more effective treatments for recurrent C difficile infections
mRNA Vaccine Shows Potential for C difficile Infections
Joseph Zackular, PhD, shares insights on his team’s mRNA vaccine research for C difficile, highlighting progress in animal models and future plans for human trials.